Growth and Development in Children withCardiac Intervention before the age of 5
Not Applicable
- Conditions
- Health Condition 1: Q20-Q28- Congenital malformations of the circulatory system
- Registration Number
- CTRI/2024/03/064119
- Lead Sponsor
- Dr Krishanu Sabyasachi Mukhopadhyay
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who underwent corrective Cardiac Surgery or Catheter based Intervention for Congenital Heart Disease before the age of 5
At the Time of enrollment, at least 1 year has elapsed since the last corrective procedure was performed on the child.
Exclusion Criteria
History of Birth Asphyxia or HIE.
History of stormy neonatal period with exclusive focus on those who suffered from Severe Intracranial Hemorrhage Meningitis Neonatal Seizures Sepsis TORCH infection and Neonatal Hyperbilirubinemia requiring Exchange Transfusion
Extreme Prematurity at birth less than 28 weeks of gestation
Syndromic etiology of Congenital Heart Disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eurodevelopmental assessment based on the developmental quotient and categorized into <br/ ><br>Normal Neurodevelopmentally- DQ greater than 85 <br/ ><br>Mild Neurodevelopmental Delay- DQ between 71 to 84 <br/ ><br>Severe Neurodevelopmental Delay DQ less than 70 <br/ ><br>Final Growth assessment will be based on the Z score for weight age- <br/ ><br>Normal Growth <br/ ><br>Mild Growth failure -1SD to -2SD <br/ ><br>Moderate Growth Failure -2SD to -3SD. <br/ ><br>Severe Growth Failure less than -3SD <br/ ><br> <br/ ><br>Timepoint: At Baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method Positive or negative correlation of Growth Failure & Neurodevelopmental delay with other factors present in the study population.Timepoint: At Baseline